Scientific Sessions 2024  /  Cutting-Edge Genetic and Precision Therapies in Cardiovascular Disease  /  Gene Therapy for Rare Cardiovascular Diseases
Logo

American Heart Association

  2
  0

Final ID:

Gene Therapy for Rare Cardiovascular Diseases

If you are unable to find a person you would like to add, enter their first name, last name, email, institution, role title, and Primary or Alternate below. Only add them once you have ensured you cannot find them in the AHA Database::
  • Mcnally, Elizabeth  ( NORTHWESTERN UNIVERSITY , Chicago , Illinois , United States )
  • Bursac, Nenad  ( DUKE UNIVERSITY, BIOMEDICAL ENGINEE , Durham , North Carolina , United States )
    • Author Disclosures:
    Elizabeth McNally: DO have relevant financial relationships ; Consultant:Amgen:Active (exists now) ; Speaker:Regeneron:Past (completed) ; Ownership Interest:Ikaika Therapeutics:Active (exists now) ; Advisor:PepGen:Active (exists now) ; Advisor:Tenaya:Active (exists now) ; Consultant:Cytokinetics:Past (completed) | Nenad Bursac: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Cutting-Edge Genetic and Precision Therapies in Cardiovascular Disease

Sunday, 11/17/2024 , 03:30PM - 04:45PM

Cardiovascular Seminar

More abstracts on this topic:
siRNA for Treatment of Hypertension

Desai Akshay, Bakris George

Precision-Based Small Molecule Therapeutics

Ho Carolyn, Ahmad Ferhaan

More abstracts from these authors:
Panel Participant

Mcnally Elizabeth, Lloyd-jones Donald

The JCI

Mcnally Elizabeth

You have to be authorized to contact abstract author. Please, Login
Not Available